A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous Infusions of ABBV-951 in Subjects With Parkinson's Disease
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to AbbVie
Related studies linked through entity extraction aliases.
A Study of Rovalpituzumab Tesirine Administered in Combination With Nivolumab and With or Without Ipilimumab for Adults With Extensive-Stage Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Intravenous Paricalcitol in Chronic Hemodialysis Patients
- Status
- UNKNOWN
- Phase
- PHASE4
A Study to Assess Efficacy and Safety of Two Different Dose Regimens of Risankizumab Administered Subcutaneously in Japanese Subjects With Generalized Pustular Psoriasis or Erythrodermic Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Assess Safety and Effectiveness of Adalimumab for Treating Children and Adolescents With Crohn's Disease in Real Life Conditions
- Status
- TERMINATED
- Phase
- N/A
A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
MHH-HCV-NPM-Neuropsychiatric Manifestations of HCV-infection During and After Treatment With OBV/PTV/r and DSV
- Status
- TERMINATED
- Phase
- PHASE4
Quality of Life Measurement in Treatment Naïve Patients With Hepatitis C Virus (HCV) Genotype 1 (GT1) Suffering From Fatigue and Receiving Ombitasvir, Paritaprevir, and Ritonavir and Dasabuvir (Viekirax®/Exviera®)
- Status
- COMPLETED
- Phase
- N/A
Post-Marketing Surveillance of Adalimumab in Korean Hidradenitis Suppurativa Subjects
- Status
- COMPLETED
- Phase
- N/A
A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
BI 655066 (Risankizumab) Compared to Placebo in Japanese Patients With Moderate to Severe Chronic Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment Naïve Participants With Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy
- Status
- COMPLETED
- Phase
- PHASE3
A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Assess Retention Rate, Persistence and Adherence in Population of Spondylarthritis (Ankylosing Spondylitis and Psoriatic Arthritis) Patients Treated With Adalimumab in Routine Clinical Settings in Russian Federation
- Status
- COMPLETED
- Phase
- N/A
A Study to Investigate Safety With Risankizumab in Psoriatic Arthritis Subjects Who Have Completed Week 24 Visit of Study M16-002 (NCT02719171)
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of ABBV-8E12 in Subjects With Progressive Supranuclear Palsy (PSP)
- Status
- TERMINATED
- Phase
- PHASE2
Expanded Access With ABT-888 (Veliparib) to Treat Metastatic Breast Cancer
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Study Evaluating the Impact of Venetoclax on the Quality of Life for Subjects With Relapsed (Your Cancer Has Come Back) or Refractory (no Response to Previous Cancer Treatments) Chronic Lymphocytic Leukemia (CLL) While Receiving Venetoclax Monotherapy (a Single Agent).
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Assess the Safety and Effectiveness of Palivizumab Administered to Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infection in the Russian Federation and the Republic of Belarus
- Status
- COMPLETED
- Phase
- PHASE3
A Study of of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection
- Status
- COMPLETED
- Phase
- PHASE3